advertisement
The Board of Control for Cricket in India (BCCI) on Tuesday, 30 July, announced that opener Prithvi Shaw had failed a dope test and has therefore been banned till November 15. It was also mentioned that his period of ineligibility has been deemed to have started on March 16.
But BCCI officials are not too pleased with the ineligibility period calculation as that also involves the time when he was plying his trade for Delhi Capitals in the 2019 edition of the Indian Premier League (IPL).
Speaking to IANS, a senior BCCI official pointed at the ruling and said that this decision just doesn't seem right because what this provision - as per BCCI Anti-Doping Rule (ADR) Article 10.10.2 - also means is that he played the IPL during the mentioned period of ineligibility.
“Where is the deterrence then if you are going to have the luxury of having played during the ‘deemed’ period of ineligibility”, the official further added.
Another official pointed out how the episode highlights Shaw's lack of awareness in not checking on the ingredients in the medicine that he brought over the counter.
Shaw had provided a urine sample as part of the BCCI's anti-doping testing program during the Syed Mushtaq Ali Trophy match on 22 February in Indore.
His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances.
On 16 July, Shaw was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI ADR Article 2.1 and provisionally suspended pending determination of the charge.
(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)